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could involve schedules employing fewer fractions than CFRT, 
but more than in a typical SBRT treatment while partly 
escalating the fractional dose. It was the purpose of this 
study to investigate heterogeneous fractionation patterns 
with respect to the dose per fraction, taking into account the 
spatial and dynamic aspects of the tumour oxygenation and 
the effect of accelerated repopulation of tumour cells in 
treatments extending over several weeks. 
Materials and Methods: Three-dimensional in silico tumours 
with heterogeneous oxygenation were simulated based on 
previous calculations from intervessel distance distributions. 
Homogeneous dose delivery was simulated employing 2 Gy 
per fraction as baseline and partly escalating the dose to 3 
and 4 Gy per fraction corresponding to fractions delivered 
prior to or directly following a short interruption of the 
treatment as represented by the weekends. Survival was 
assessed on voxel level with the linear-quadratic (LQ) model 
taking into account the dose-modifying effect of the 
oxygenation. The effect of accelerated repopulation was 
incorporated assuming a kick-off time of 14 days and a 
potential doubling time of 5 days for NSCLC. Local control 
was evaluated as tumour control probability (TCP) through a 
Poisson-based model and dose-response curves were 
generated by systematically varying the total dose. 
Results: For tumours with a negligible level of spread-out 
hypoxia (left panel of Figure 1) and assuming that 
accelerated repopulation starts after two weeks, partly 
increasing the fractional dose could substantially improve 
local control even if no reoxygenation takes place. If however 
the effects of repopulation are neglected and the hypoxia is 
geometrically concentrated instead of being spread out 
throughout the tumour, the impact of reoxygenation is far 
more important than partly escalating the fractional dose, 
even for small hypoxic fractions (right panel of Figure 1). 
 
 
Conclusions: Heterogeneous fractionation might ensure high 
levels of control in well-oxygenated tumours even when 
inter-fraction reoxygenation cannot be assumed. For tumours 
with more concentrated hypoxia, moderately heterogeneous 
fractionation patterns cannot counteract the increased 
radioresistance of tumour hypoxia.  
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Purpose/Objective: Dose given to the tumour in patients 
with locally-advanced pancreatic cancer (LAPC) is limited by 
normal tissue toxicity in the gastrointestinal tract. The close 
proximity of the duodenum to the target volume therefore 
makes studying the link between duodenal dose and 
treatment outcome of interest. This study investigates the 
effect of changes in size and position of the duodenum 
throughout treatment on dosimetric parameters. 
Materials and Methods: Three patients from the ARCII trial 
(EudraCT 2008-006302-42) treating LAPC with 
chemoradiotherapy were chosen for this study. CBCTs from 
fractions 6, 12, 18 and 24 were fused with the planning CT 
using a bony and soft tissue match. The duodenum was 
contoured on the planning CT and each CBCT by a single 
physician. The contours were copied to the ARCII trial 3D 
conformal plan prescribing 50.4Gy in 28 fractions to the PTV 
with a subsequent boost of 9Gy in 5 fractions to a smaller 
PTV for a total of 59.4Gy. The total volume of the duodenum 
and the percentage of the duodenum outside of the PTV (% 
out) were recorded together with V35 and V55 from the 
duodenum dose surface histograms (DSHs). 
Results: The volume of the duodenum on the planning CT and 
the range of duodenum volumes over the 4 CBCT contours 
were 86.6cm3 (56.7 - 71.9), 41.6cm3 (45.9 - 80.6) and 
93.1cm3 (76.7 - 132.7) for patients 1, 2 and 3 respectively. 
Figure 1 shows large interfraction variation in the volume of 
the duodenum. There is also variation in the percentage of 
the duodenum located outside the PTV. It is also seen that as 
more of the duodenum is found outside the PTV, the dose 
volume metrics of the duodenum are reduced. There is no 
such link to absolute volume change. 
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Conclusions: Results confirm previous studies showing large 
variation in duodenum volume between fractions in a given 
patient. For patients where the duodenum and PTV overlap, 
evaluation of volume receiving dose around 30-55Gy presents 
the largest error due to interfraction differences. This study 
suggests that a reduction in dose volume metrics of the 
duodenum is likely to be due to an increase in the percentage 
of the duodenum located outside the PTV. However, this 
parameter still suffers from interfraction effects. 
These finding suggest that toxicity predictions based on 
either duodenum volume, percentage of duodenum outside 
PTV or the DSH from the planning CT alone may be 
inaccurate. Further work needs to be undertaken in order to 
better estimate toxicity. 
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Purpose/Objective: Microbeam Radiation Therapy (MRT) is a 
still preclinical radiotherapy approach that uses synchrotron 
radiation to shape arrays of 25-100 µm wide planar beams 
separated by a few 100 µm. It places particular high hopes on 
the treatment of infantile, inoperable brain tumours. Several 
preclinical studies revealed an extremely high tolerance of 
normal tissue to these irradiation patterns while tumours 
were effectively controlled. Whereas several preclinical 
studies were able to impressively confirm the differential 
effect and the normal tissue sparing, a satisfying explanation 
does not yet exist. Apart from bystander effects the vessel 
system was identified to play an important role. 
Regeneration and repair originating in the tissue in the low 
dose regions could be responsible for a rapid recovery after 
treatment. By simulating irradiations of a computer modelled 
vascular system we investigate the possibility of a geometric 
explanation. 
Materials and Methods: We simulated a cerebral cortical 
vascular and capillary network fitting important observed 
physiological parameters such as the vessel radii. Based on 
observed cell survival curves a radiation response model was 
developed for vessels and capillaries. After a simulated 
irradiation with either microbeams or a seamless beam at the 
same mean dose the vascular length and the average cell-
vessel distance was assessed as a biological endpoint.  
Results: Although our model does not incorporate repair 
mechanisms or bystander effects spatially fractionated beam 
geometries show a clear tissue sparing effect compared to 
seamless irradiations (s. figure). This effect increases with an 
increasing peak to valley dose ratio (PVDR). We were able to 
attribute this effect to a convex dose-response relationship. 
Furthermore we were able to show that the vascular network 
morphology has a strong influence on the tissue damage after 
MRT exposure. Especially the distribution of vessel radii 
appears to be crucial. This may explain the differential effect 
on tumours and normal tissue. 
 
 
Conclusions: Even without taking into account repair 
mechanisms and bystander effects, a tissue sparing effect of 
MRT may be explained by a convex dose-response 
relationship. Assuming realistic treatment parameters an 
increase in the blood vessel surviving fraction by a factor of 3 
is supported in our simulations. More accurate experimental 
data on dose dependent cell survival and on tumour 
vasculature will help to enable a more quantitative and 
predictive analysis.  
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